Successfully Dealing with Business, Regulatory, and Intellectual Property Challenges for Israeli BioMed Companies
04 June 2007
In cooperation with leading Israeli law office Gross, Kleinhendler, Hodak, Helevy, Greenberg & Co. (GKH), Foley was proud to organize and participate in the conference held in Tel Aviv. The conference addressed challenges faced by Israeli Biomedical companies in successfully dealing with business, regulatory, and intellectual property challenges.
Several Foley attorneys participated in the conference, including:
- Benjamin Berkowitz, associate, Intellectual Property Department
- Lena Robins, senior counsel, Healthcare Industry Team
- David Rosen, co-chair, Life Sciences Industry Team, and lead, FDA Regulatory Practice
- Keith Lindenbaum, partner, Intellectual Property Department
- Richard Peet, partner and chair, International Business Industry Team and Chemical & Pharmaceutical Practice
People
Related Insights
21 May 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part III)
We complete the series on “Customs Enforcement and False Claims Act Risks” with Part III, which focuses on preparing for the most common FCA risks arising from improper management of import operations.
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.